+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Ophthalmoscopes Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163035
The global ophthalmoscopes market size was valued at USD 253.69 Million in 2024, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 5.50% during the forecast period of 2025-2034 to achieve a value of USD 433.34 Million by 2034 .

Ophthalmoscopes: Introduction

Ophthalmoscope is a device that enables the investigation of the back of the eye to look at the health of the retina, optic nerve, vasculature, and vitreous humor. This exam produces an upright image of approximately 15 times magnification. The large aperture is used for a dilated pupil after administering mydriatic drops.

Global Ophthalmoscopes Market Analysis

The growth of the market is supported by the increasing development in the ophthalmoscope sector. The increasing advancements to improve the efficacy and overall performance of ophthalmoscopes with additional features are contributing significantly to the market growth. For example, a new multicolour video-ophthalmoscope has been developed lately, which is based on the existing mono-colour video-ophthalmoscope that allows healthcare professionals to measure the spectral distribution of light absorption of blood in the human retina with the use of narrow-band transmission filters. Such developments are expected to propel the global ophthalmoscope market growth.

In October 2023, Baxter International Inc., one of the leading companies in patient monitoring, physical assessment, and vision screening products, announced the launch of digital image capture capability, for eye examination with the use of their Welch AllynPanOptic Plus Ophthalmoscope. The iExaminer Pro System adds a key technology to routine eye examinations, designed to help advance healthcare professionals' ability to examine and diagnose the eye health of patients. Such innovations are set to not only enhance patient outcomes but provide convenience to healthcare professionals, propelling the market growth further.

Global Ophthalmoscopes Market Segmentations

Ophthalmoscopes Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

  • Direct Ophthalmoscopes
  • Indirect Ophthalmoscopes

Market Breakup by Light Source

  • Halogen Illumination Ophthalmoscopes
  • Xenon Illumination Ophthalmoscopes
  • LED Illumination Ophthalmoscopes

Market Breakup by Application

  • Glaucoma
  • Retinal Diseases
  • Diabetes Eye Diseases
  • Others

Market Breakup by End User

  • Hospitals
  • Speciality Clinics
  • Eye Institutes
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Ophthalmoscopes Market Overview

The market growth is significantly driven by factors such as growing geriatric population, due to which the prevalence of eye diseases is also increasing. The continuous advancements in technology are also driving the market growth further. For instance, according to a WHO report published in 2022, nearly 2.2 billion of the population was suffering from near or distant vision impairment worldwide. The leading cause of this vision impairment in geriatric population is often considered to be age-related macular degeneration, glaucoma, and diabetic retinopathy.

The adaptation of sedentary lifestyle by people has also collectively resulted in the increased incidence of various diseases leading to visual impairment, such as diabetes and hypertension. All these factors are substantially driving the ophthalmoscopes market demand. Due to the increased incidence of eye diseases, there has been a considerable rise in the number of ophthalmic procedures being performed, enhancing the demand for ophthalmoscopes devices, further propelling the market growth.

Geographically, North America has been dominating the global ophthalmoscopes market share and is expected to dominate for the forecast period as well. The regional growth is influenced by increasing prevalence of eye diseases and disorders, such as diabetic retinopathy, age-related macular degeneration, and glaucoma requiring regular eye examination behaving as a primary factor driving the market growth of the ophthalmoscopes. For instance, according to an article published by the brain focus foundation earlier this year nearly 20 million American adults are suffering from age-related macular degeneration (AMD).

Global Ophthalmoscopes Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Welch Allyn
  • Zumax medical co. ltd
  • Keeler Ltd.co
  • Neitz Instruments Co., Ltd.
  • Albert Waeschle
  • Heine USA Ltd
  • HONSUN Group
  • Rudolf Riester GmbH
  • US Ophthalmic
  • Dino-Lite Europe
  • GlobalMed
  • Carl Zeiss Meditec AG

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ophthalmoscopes Market Overview
3.1 Global Ophthalmoscopes Market Historical Value (2018-2024)
3.2 Global Ophthalmoscopes Market Forecast Value (2025-2034)
4 Global Ophthalmoscopes Market Landscape
4.1 Global Ophthalmoscopes Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ophthalmoscopes Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Light Source
4.2.3 Analysis by Application
5 Global Ophthalmoscopes Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ophthalmoscopes Market Segmentation
6.1 Global Ophthalmoscopes Market by Product Type
6.1.1 Market Overview
6.1.2 Direct Ophthalmoscopes
6.1.3 Indirect Ophthalmoscopes
6.2 Global Ophthalmoscopes Market by Light Source
6.2.1 Market Overview
6.2.2 Halogen Illumination Ophthalmoscopes
6.2.3 Xenon Illumination Ophthalmoscopes
6.2.4 LED Illumination Ophthalmoscopes
6.3 Global Ophthalmoscopes Market by Application
6.3.1 Market Overview
6.3.2 Glaucoma
6.3.3 Retinal Diseases
6.3.4 Diabetes Eye Diseases
6.3.5 Others
6.4 Global Ophthalmoscopes Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Speciality Clinics
6.4.4 Eye Institutes
6.4.5 Ambulatory Surgical Centres
6.4.6 Others
6.5 Global Ophthalmoscopes Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Ophthalmoscopes Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ophthalmoscopes Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ophthalmoscopes Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ophthalmoscopes Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ophthalmoscopes Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Welch Allyn
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Zumax Medical Co. Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Keeler Ltd. Co.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Neitz Instruments Co., Ltd.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Albert Waeschle
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Heine USA Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 HONSUN Group
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Rudolf Riester GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 US Ophthalmic
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Dino-Lite Europe
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 GlobalMed
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Carl Zeiss Meditec AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Ophthalmoscopes Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Welch Allyn
  • Zumax Medical Co. Ltd
  • Keeler Ltd. Co.
  • Neitz Instruments Co., Ltd.
  • Financial Portfolio
  • Albert Waeschle
  • Heine USA Ltd.
  • HONSUN Group
  • Rudolf Riester GmbH
  • US Ophthalmic
  • Dino-Lite Europe
  • GlobalMed
  • Carl Zeiss Meditec AG